Effect of 8 Weeks Moderate & High Intensity Training on Cognitive Functions and Sleep of Female Students

January 18, 2024 updated by: Riphah International University
this study aims to assess ther effectiveness of moderate & high intensity training on cognitive functions and sleep of female students

Study Overview

Status

Recruiting

Conditions

Detailed Description

In group A for moderate intensity training brisk walk will be performed(HR will be between 50%- 60% of maxHR).

warmup exercise will be performed to achieve 50%HR and then brisk walk will be performed till she reaches 60%HR.

This protocol will be followed for 5days per week. In group B for high intensity training skipping rope will performed (HR will be between 70%-85% of maxHR).

warmup exercise will be performed to achieve 70%HR and then skipping rope will be performed till she reaches 85%HR.

This protocol will be followed for alternative 3days per week.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Punjab
      • Sargodha, Punjab, Pakistan, 40100
        • Recruiting
        • Sargodha institute of health sciences
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Tanzeela Rahman, DPT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • female students
  • age between 18- 25

Exclusion Criteria:

  • History of trauma/ injury
  • mental illness
  • physical deformity
  • infection,fever

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A ( moderate intensity training)
warm up protocol to reach maxHR 50% than moderate intensity exercise. Group A will be given moderate intensity exercise i.e brisk walk will be performed.(HR will be between 50-60%).
Arm Circles, Leg Swings, Lunges, brisk walk
Experimental: Group B( high intensity training)
warm up protocol to achieve 70% of maxHR . group Bwill be given highintensity exercise i.e skipping rope ( HR will be between 70-85%).
Arm circles, Leg swings, Lunges, skipping rope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroop test for Cognitive Function
Time Frame: 8 weeks
The Stroop Color and Word Test, interference on reading ability through three sections: word page, color page, and word-color page, each containing 5 columns with 20 items. In a 45-second timeframe, participants rapidly read words or name ink colors. Overall, the Stroop test offers a comprehensive evaluation of cognitive abilities related to interference and reading skills.
8 weeks
Pittsburg sleep quality index ,
Time Frame: 8 weeks
Each of the seven component scores, encompassing subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction, is assigned a value on a scale ranging from 0 to 3. A score of 0 signifies an absence of difficulty, while a score of 3 reflects severe difficulty within the specific component. The calculation of the Global Pittsburgh Sleep Quality Index (PSQI) score involves summing up these seven component scores, resulting in a total score that ranges from 0 to 21. Elevated global scores are indicative of lower sleep quality, and a score exceeding 5 is generally construed as suggestive of poor sleep. In terms of interpretation, a global PSQI score falling between 0 and 5 is considered representative of "good" sleep quality, while a score surpassing 5 implies a lower quality of sleep.
8 weeks
Digit span test
Time Frame: 8 weeks
The Digit Span Test gauges short-term memory and attention span by having individuals repeat digit sequences in the same or reverse order. Scores are assigned per correctly repeated digit, with the test progressively increasing in difficulty. The total score reflects the longest accurately recalled sequences in both conditions. Interpretation reveals insights into working memory and attentional control, where a higher Digit Span Forward score signifies efficient short-term memory, while a higher Digit Span Backward score indicates superior working memory and cognitive flexibility in recalling and manipulating sequences in reverse order.
8 weeks
Sleep quality scale
Time Frame: 8 weeks

The Sleep Quality Scale (SQS) measures sleep quality in people who live in the general population.

Using a four-point, Likert-type scale, respondents indicate how frequently they exhibit certain sleep behaviors (0 = "few," 1 = "sometimes," 2 = "often," and 3 = "almost always"). Scores on items belong to factors 2 and 5 (restoration after sleep and satisfaction with sleep) and are reversed before being tallied. Total scores can range from 0 to 84, with higher scores demoting more acute sleep problems.

8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tabinda Kanwal, Riphah International University Islamabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Estimated)

March 15, 2024

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

November 24, 2023

First Submitted That Met QC Criteria

January 18, 2024

First Posted (Actual)

January 30, 2024

Study Record Updates

Last Update Posted (Actual)

January 30, 2024

Last Update Submitted That Met QC Criteria

January 18, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 014244 tabinda

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe